Prof. Fortunato Vesce - Elenco delle Pubblicazioni
Pubblicazioni su riviste internazionali con referees (1968 -1987)
1) F. Vesce, V. Scoppetta, G. Cocilovo.
Asherman’s syndrome associated with hypoovaria, hypothyroidism and galactorrhoea.
Clin Exp Obst Gyn 1978; V, 3-4:121-124.
2) F. Vesce, G. Cocilovo, G. Tataranni, N. Guzzinati, G. Lo Gallo.
Amniotic fluid beta2-microglobulin as an index of fetal maturity.
Clin Exp Obst Gyn 1981; VIII, 2:66-69.
3) F. Vesce, C, Biondi.
Alpha-L-fucosidase activity in endometrial, cervical and ovarian cancer.
Eur J Gynaec Oncol 1983; IV, 2:135-138.
4) F. Vesce, C. Biondi, A. M. Gulinati, C Zeni, V. Simonetti, G. Salvatorelli.
In vitro effect of progesterone on alpha-L-fucosidase activity of human endometrium.
Eur J Gynaec Oncol 1985; VI, 2:154-156.
5) F. Vesce, P. Garutti, V. Scoppetta, G. Perri, P. De Salvo, V. Simonetti
Hemolytic disease of the newborn secondary to anti-FYa and anti-S.
Clin Exp Obst Gyn 1985; XII, 3-4:1-3.
6) F. Vesce, G. Cocilovo, V. Simonetti.
Sonographic picture of submembranous haematoma.
Clin Exp Obst Gyn 1985; XII, 3-4:90-92.
7) F. Vesce, P. Guerrini, G. Perri, L. Cavazzini, V. Simonetti.
Ultrasonographic diagnosis of ectasia of the umbilical vein.
J Clin Ultrasound 1987; 15:346-349.
Pubblicazioni su riviste internazionali con referees (1987 -1993)
8) F. Vesce, P. Garutti, E. Grandi, G. Perri, G. Altavilla.
Prenatal diagnosis of cystic adenomatoid malformation of the lung.
Clin Exp Obst Gyn 1989; XVI, 4:121-125.
9) R. Chierici, G. Riccipetitoni, L Tamisari, F. Vesce, B. Zanella, L Merlo, V. Vigi.
Conservative management of urinary abnormalities detected in utero.
Fetal Ther 1989; 4:43-48.
10) F. Pansini, C. M. Bergamini, B. Bagni, M. Linciano, L. Condemi, G. Bonaccorsi, F. Vesce.
Studies on amniotic prolactin: chromatographic pattern and correlation with the lecithin content.
Gynecol Obstet Invest 1989; 27: 126-128.
11) F. Vesce, C. Biondi, A. Portolan, L. Condemi, S. Travagli, A. L. Campi, F. Colla.
Adenylate cyclase and cyclic AMP phosphodiesterase activities of fetal membranes: effect of insulin.
Clin Exp Obst Gyn 1989; XVI, 2-3:65-72.
12) A. Sensi, S. Cerruti, E. Calzolari, F. Vesce.
Familial porencephaly.
Clin. Genet 1990; 38:396-397
13) P. Guerrini, F. Vesce, F. Colla, S. Travagli, G. Cocilovo.
Contribution to the assessment of steroid therapy in the prevention of respiratory distress syndrome in the neonate.
Clin Exp Obst Gyn 1990;XVII, 3-4:145-149.
14) F. Vesce, S. Travagli, G. Cocilovo.
Predictive value of the gestosis index.
Journal of Obstetrics and Gynaecology 1992; 12:22-23.
15) S. Travagli, M. C. Leonardi, G. Cocilovo, F. Vesce
Fetal macrosomia: predictive value of maternal glycaemic profiles, oral glucose tolerance test and ultrasound measurements.
Journal of Obstetrics and Gynaecology 1992; 12:9-13.
16) F. Vesce, M. C. Pareschi, S. Travagli, C. Tarabbia, F. Pansini, G Salvatorelli, A. M. Gulinati, E. Grandi, C. Biondi.
Betamethasone-induced lecithin release in vitro from the fetal membranes.
Gynecol Obstet Invest 1992; 33:134-137.
17) G. Cocilovo, A. Di Leo, F. Vesce, G. Mollica.
Cesarean section trend: a 10-year review of incidence, indication and risk in a University Hospital.
Italian Journal of Gynaecology and Obstetrics 1993; 3:81-84.
18) F. Vesce, S. Travagli, A. Farina, G. Cocilovo
Evaluation of independent prognostic factors in pregnancy induced hypertension using a stepwise logistic regression.
Journal of Obstetrics and Gynaecology 1993; 13:419-422.
Pubblicazioni su riviste internazionali con referees (1994 -1997)
19) A.Virgili, M. Corazza, F. Vesce, P. Garutti, G Mollica, A. Califano.
Pemphigus in pregnancy.
Acta Derm Venereol 1994; 75:172-173
20) F. Vesce, C. Tarabbia, A. Farina, S. Travagli, M. C. Pareschi, A. Portolan, C. Biondi.
Modulation of amnionic adenylyl cyclase and cAMP phosphodiesterase by prostaglandins E1 and F2alfa.
Gynecol Obstet Invest 1994; 37:77-82.
21) F. Vesce, C. Biondi, M. E. Ferretti, M. C. Pareschi, R. Cavallaro, M. Buzzi, A Farina.
Epidermal Growth Factor stimulation of lecithin release by human amnion.
Gynecol Obstet Invest 1994; 38:100-103.
22) G. Cocilovo, M. C. Leonardi, F. Vesce, G. Mollica.
Cut-off values of laboratory measurements of capillary blood glucose in a glucose challenge test. Evaluation of 250 cases.
Journal of Obstetrics and Gynaecology 1994; 14:76-78
23) F. Vesce, C. Biondi, M. E. Ferretti, M. C. Pareschi, M. Buzzi, M. L. Colamussi.
The controversial role of cAMP on amnionic prostaglandin release: effect of adenylate cyclase inhibition.
Gynecol Obstet Invest 1995; 40:73-79.
24) F.Vesce, A. Farina, G. Iorizzo, C. Tarabbia, O Calabrese, D. Pelizzola, G. Giovannini, A. Piffanelli.
Raised level of amniotic endothelin in pregnancy with fetal aneuploidy.
Fetal Diagnosis and Therapy 1996; 11:94-98.
25) M. Lunghi, A. L. Giuliani, P. Melandri, P. Ferron, L. Cavazzini, G. Stabellini, F. Vesce, G. Berti.
Analogs of cord red blood cell membrane components displayed on placenta, amnion and amniotic cells in culture.
Eur J Histochem 1996; 40:129-136.
26) M. Lunghi, A. L. Giuliani, M. Torboli, G. Guerra, F. Vesce, G. Salsini, E. Wiener, G. Berti.
Red blood cells expressing fetal antigens: their presence in adults with certain forms of anemia. Acta Haematol 1996; 96:29-35.
27) F. Vesce, A. Farina, M. Giorgetti, G. Iorizzo, A. Bianciotto, O. Calabrese, G. Mollica. Increased incidence of pre-eclampsia in pregnancies complicated by fetal malformation.
Gynecol Obstet Invest 1997; 44:107-111
Pubblicazioni su riviste internazionali con referees (1998 -2000)
28) F. Vesce, M. Buzzi, M. E. Ferretti, B. Pavan, A. Bianciotto, G. Iorizzo, C. Biondi.
Inhibition of amniotic prostaglandin E2 release by ampicillin.
Am J Obstet Gynecol 1998; 178(4):759-764.
29) M. Buzzi, F. Vesce, M. E. Ferretti, E. Fabbri, C. Biondi.
Does formyl-methionyl-leucyl-phenylalanine exert a physiological role in labor in women?
Biol Reprod 1999; 60:1211-1216.
30) A.Farina, F. Vesce, P. Garutti, G. Iorizzo, A. Bianciotto.
Evaluation of intrauterine growth pattern of twins by linear discriminant analysis of the value of biparietal diameter, femur length and abdominal circumference.
Gynecol Obstet Invest 1999; 48:14-17.
31) A.Farina, F. Vesce, A. Sekizawa, M. Barbieri.
A multivariate approach in statistical analysis for perinatal research: Cox regression analysis.
Journal of Obstetrics and Gynaecology 1999; 19:69-70.
32) F. Vesce, B. Pavan, M. Buzzi, M. C. Pareschi, A. Bianciotto, G. Iorizzo, C. Biondi.
Effect of different classes of antibiotics on amniotic prostaglandin E release.
Prostaglandins & other Lipid Mediators 1999; 57:207-218.
33) B. Pavan, F. Vesce
Sitafloxacin
Review ad invito dell’editore, su Current Opinion in Anti-infective Investigational Drugs 1999;1(4):478-487.
34) F. Vesce, G. Iorizzo, A. Bianciotto, G. Gotti.
Use of the copper intrauterine device in the management of secondary amenorrhea.
Fertil Steril 2000; 73:162-5
35) B. Pavan, M. Buzzi, F. Ginanni-Corradini, M. E. Ferretti, F. Vesce, C. Biondi.
Influence of oxytocin on prostaglandin E2, intracellular calcium, and cyclic adenosine monophosphate in human amnion-derived (WISH) cells.
Am J Obstet Gynecol 2000; 183:76-82.
Pubblicazioni su riviste internazionali con referees (2001-2004)
36) F. Vesce, C. Scapoli, G. Giovannini, A.Piffanelli, A. Geurs-Moespot, F. C. G. J. Sweep.
Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies.Obstet Gynecol 2001; 97:404-8
37) C. Biondi, B. Pavan, M. E. Ferretti, F. Ginanni-Corradini, L. M. Neri, F. Vesce.
Formyl-Methionyl-Leucyl-Phenylalanine induces Prostaglandin E2 release from human amnion-derived WISH cells by Phospholipase C-mediated (Ca2+) rise.
Biol Reprod 2001; 64, 865-870
38) B. Pavan, F. Vesce.
Sitafloxacin (update).
Investigational Drugs database, 15 October 2001
39) F. Vesce, C. Scapoli, G. Giovannini, L. Tralli, G. Gotti, A. Valerio, A. Piffanelli.
Cytokine imbalance in pregnancies with foetal chromosomal abnormalities.
Hum Reprod 2002;17:803-808
40) C. Biondi, S. Fiorini, I. Boarini, L. Barbin, F. Cervellati, M. E. Ferretti and F. Vesce
Effect of Nitric Oxide on Arachidonic Acid Release From Human Amnion-Like WISH Cells.
Placenta (2002), 23, 575-83
41) B. Pavan, S. Fiorini, M.E. Ferretti, F. Vesce, C. Biondi.
WISH cells as a model for “in vitro” study of amnion pathophysiology.
Curr Drug Targets Immune Endocr Metabol Disord. 2003; 3:83-92.
42) G. Pelizzo, G. Conoscenti, K. D. Kalache, F. Vesce, P. Guerrini, L. Cavazzini
Antenatal manifestation of congenital pancreatoblastoma in a fetus with Beckwith-Wiedemann syndrome.
Prenatal Diagnosis 2003; 23:292-294
43) C. Biondi, S. Fiorini, I. Boarini, B. Pavan, M. E. Ferretti, P. Barion, F. Vesce.
Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells.
J Reprod Immunol 2003; 60: 35-52.
44) F. Vesce, B. Pavan, L. Lunghi, G. Giovannini, C. Scapoli, A. Piffanelli, C. Biondi
Inhibition of Amniotic Interleukin-6 and Prostaglandin E2 Release by Ampicillin.
Obstetrics & Gynecology 2004; 103:108-113.
45) F. Vesce.
Oxidative balance: from chemistry to clinical medicine.
Curr. Pharm. Design 2004;10: 1609-10.
Pubblicazioni su riviste internazionali con referees (2005-2008)
46) F. Vesce.
Oxidative balance: experimental and clinical perspectives.
Curr. Pharm. Design, 11, 2005, in corso di stampa.
47) C. Biondi, B. Pavan, L. Lunghi, S. Fiorini, F.Vesce.
The role and modulation of the oxidative balance in pregnancy.
Curr Pharm Design 2005; 11, in corso di stampa.
48) Biondi C, Ferretti ME, Pavan B, Lunghi L, Gravina B, Nicoloso MS, Vesce F, Baldassarre G. Prostaglandin E2 inhibits proliferation and migration of HTR-8/SVneo cells, a human trophoblast-derived cell line.
Placenta. 2006 Jun-Jul;27(6-7):592-601. Epub 2005 Sep 12.
49) Biondi C, Pavan B, Dalpiaz A, Valerio A, Spisani S, Vesce F.
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour.
J Reprod Immunol. 2005 Dec;68(1-2):71-83. Epub 2005 Oct 19.
50) Biondi C, Pavan B, Dalpiaz A, Medici S, Lunghi L, Vesce F. Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs.
Mol Hum Reprod. 2007 Jan;13(1):77-83. Epub 2006 Nov 8.
51) Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F.
Control of human trophoblast function.
Reprod Biol Endocrinol. 2007 Feb 8;5:6. Review.
52) Penolazzi L, Lambertini E, Tavanti E, Torreggiani E, Vesce F, Gambari R, Piva R.
Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by BIO-PLEX technology.
Cell Biol Int. 2008 Feb;32(2):320-5. Epub 2007 Sep 7.
53) Penolazzi L, Pocaterra B, Tavanti E, Lambertini E, Vesce F, Gambari R, Piva R.
Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood.
Apoptosis. 2008 Apr;13(4):553-61. doi: 10.1007/s10495-008-0188-7. Epub 2008 Feb 29
54) Biondi C, Ferretti ME, Lunghi L, Medici S, Cervellati F, Abelli L, Bertoni F, Adinolfi E, Vesce F, Bartolini G, Papi A, D’Andrea S, Berton S, Baldassarre G.
Somatostatin as a regulator of first-trimester human trophoblast functions.
Placenta. 2008 Aug;29(8):660-70. doi: 10.1016/j.placenta.2008.05.009. Epub 2008 Jul 9
Pubblicazioni su riviste internazionali con referees (2009-2012)
56) Cervellati F, Franceschetti G, Lunghi L, Franzellitti S, Valbonesi P, Fabbri E, Biondi C, Vesce F.
Effect of high-frequency electromagnetic fields on trophoblastic connexins.
Reprod Toxicol. 2009 Jul;28(1):59-65. doi: 10.1016/j.reprotox.2009.03.010. Epub 2009 Apr 5.
57) Penolazzi L, Vecchiatini R, Bignardi S, Lambertini E, Torreggiani E, Canella A, Franceschetti T, Calura G, Vesce F, Piva R.
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells.
Reprod Biol Endocrinol. 2009 Oct 5;7:106. doi: 10.1186/1477-7827-7-106.
58) Biondi C, Ferretti ME, Lunghi L, Medici S, Cervellati F, Pavan B, Vesce F, Morano D, Adinolfi E, Bertoni F, Abelli L.
cAMP efflux from human trophoblast cell lines: a role for multidrug resistance protein (MRP)1 transporter.
Mol Hum Reprod. 2010 Jul;16(7):481-91. doi: 10.1093/molehr/gaq023. Epub 2010 Mar 15.
59) Vesce F.
Glucocorticoids from chemistry to clinics.
Curr Pharm Des. 2010;16(32):3538-9. No abstract available.
60) Cervellati F, Pavan B, Lunghi L, Manni E, Fabbri E, Mascoli C, Biondi C, Patella A, Vesce F.
Betamethasone, progesterone and RU-486 (mifepristone) exert similar effects on connexin expression in trophoblast-derived HTR-8/SVneo cells.
Reprod Fertil Dev. 2011;23(2):319-28. doi: 10.1071/RD10077.
61) Lunghi L, Pavan B, Biondi C, Paolillo R, Valerio A, Vesce F, Patella A. Use of glucocorticoids in pregnancy.
Curr Pharm Des. 2010;16(32):3616-37. Review.
62) Gessi S, Merighi S, Stefanelli A, Mirandola P, Bonfatti A, Fini S, Sensi A, Marci R, Varani K, Borea PA, Vesce F.
Downregulation of A(1) and A(2B) adenosine receptors in human trisomy 21 mesenchymal cells from first-trimester chorionic villi.
Biochim Biophys Acta. 2012 Nov;1822(11):1660-70. doi: 10.1016/j.bbadis.2012.07.013. Epub 2012 Jul 31.
Pubblicazioni su riviste internazionali con referees (2012-2014)
63) Giugliano E, Cagnazzo E, Pansini G, Vesce F, Marci R.
Ovarian stimulation and liver dysfunction: Is a clinical relationship possible? A case of hepatic failure after repeated cycles of ovarian stimulation.
Clin Exp Reprod Med. 2013 Mar;40(1):38-41. doi: 10.5653/cerm.2013.40.1.38. Epub 2013 Mar 31.
64) Cervellati F, Valacchi G, Lunghi L, Fabbri E, Valbonesi P, Marci R, Biondi C, Vesce F.
17-β-Estradiol counteracts the effects of high frequency electromagnetic fields on trophoblastic connexins and integrins.
Oxid Med Cell Longev. 2013;2013:280850. doi: 10.1155/2013/280850. Epub 2013 May 30.
65) Cremonini G, Poggi A, Capucci R, Vesce F, Patella A, Marci R.
Rare case of massive congenital bilateral chylothorax in a hydropic fetus with true mosaicism 47,XXX/46,XX.
J Obstet Gynaecol Res. 2014 Jan;40(1):259-62. doi: 10.1111/jog.12131. Epub 2013 Aug 12.
66) Rotondo JC, Selvatici R, Di Domenico M, Marci R, Vesce F, Tognon M, Martini F.
Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males. Epigenetics. 2013 Sep;8(9):990-7. doi: 10.4161/epi.25798. Epub 2013 Jul 24.
67) Giugliano E, Cagnazzo E, Giugliano B, Vesce F, Caserta D, Moscarini M, Marci R.
Can Doppler study of the ovarian artery predict the fertility outcome of intrauterine insemination?
J Clin Ultrasound. 2014 Jul-Aug;42(6):331-5. doi: 10.1002/jcu.22140. Epub 2014 Feb 13
68) Vesce F, Giugliano E, Cagnazzo E, Mossuto E, Marci R.
Low dose of betamethasone throughout the whole course of pregnancy and fetal
growth: a clinical study.
Eur Rev Med Pharmacol Sci. 2014;18(4):593-8.
69) Vesce F, Giugliano E, Bignardi S, Cagnazzo E, Colamussi C, Marci R, Valente N, Seraceni S, Maritati M, Contini C.
Vaginal lactoferrin administration before genetic amniocentesis decreases amniotic interleukin-6 levels.
Gynecol Obstet Invest. 2014;77(4):245-9. doi: 10.1159/000358877. Epub 2014 Mar 7.
70) Giugliano E, Cagnazzo E, Milillo V, Moscarini M, Vesce F, Caserta D, Marci R. The risk factors for failure of labor induction: a cohort study.
J Obstet Gynaecol India. 2014 Apr;64(2):111-5. doi: 10.1007/s13224-013-0486-z. Epub 2013 Dec 1.
71) Giugliano E, Cagnazzo E, Vesce F, Giugliano B, Caserta D, Moscarini M, Caldarelli C, Stellin G, Marci R.
Doppler velocimetry of the ovarian artery as a tool to detect LH surge in stimulated cycles.
Gynecol Endocrinol. 2014 Sep;30(9):627-31. doi: 10.3109/09513590.2014.911276. Epub 2014 Jul 1.
72) Vesce F, Cagnazzo E, Giugliano E, Mossuto E, Marci R.
The behaviour of the peripheral natural killer cells in the foetal growth restriction. Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2248-52.